Boxer Capital as of June 30, 2022
Portfolio Holdings for Boxer Capital
Boxer Capital holds 76 positions in its portfolio as reported in the June 2022 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Mirati Therapeutics | 8.5 | $134M | 2.0M | 67.13 | |
Cytokinetics Com New (CYTK) | 5.2 | $83M | 2.1M | 39.29 | |
BeiGene Sponsored Adr (BGNE) | 5.1 | $81M | 500k | 161.85 | |
Revolution Medicines (RVMD) | 4.3 | $68M | 3.5M | 19.49 | |
Apellis Pharmaceuticals (APLS) | 3.7 | $59M | 1.3M | 45.22 | |
Springworks Therapeutics (SWTX) | 3.2 | $51M | 2.1M | 24.62 | |
Pmv Pharmaceuticals (PMVP) | 3.2 | $50M | 3.5M | 14.25 | |
Prometheus Biosciences | 3.1 | $48M | 1.7M | 28.23 | |
Tyra Biosciences (TYRA) | 2.9 | $46M | 6.4M | 7.15 | |
Relay Therapeutics (RLAY) | 2.8 | $45M | 2.7M | 16.75 | |
Iteos Therapeutics (ITOS) | 2.8 | $44M | 2.2M | 20.60 | |
Merus N V (MRUS) | 2.7 | $43M | 1.9M | 22.64 | |
Turning Point Therapeutics I | 2.7 | $43M | 571k | 75.25 | |
Amylyx Pharmaceuticals (AMLX) | 2.7 | $42M | 2.2M | 19.26 | |
Reata Pharmaceuticals Cl A | 2.4 | $38M | 1.2M | 30.39 | |
Spdr Ser Tr S&p Biotech (XBI) | 2.4 | $37M | 500k | 74.27 | |
Arcus Biosciences Incorporated (RCUS) | 2.3 | $36M | 1.4M | 25.34 | |
Sage Therapeutics (SAGE) | 2.2 | $35M | 1.1M | 32.30 | |
Tango Therapeutics (TNGX) | 2.0 | $31M | 6.9M | 4.53 | |
Ideaya Biosciences (IDYA) | 1.9 | $30M | 2.2M | 13.80 | |
Bellus Health Com New | 1.9 | $30M | 3.2M | 9.24 | |
Anaptysbio Inc Common (ANAB) | 1.7 | $26M | 1.3M | 20.30 | |
Blueprint Medicines (BPMC) | 1.6 | $26M | 507k | 50.51 | |
Amicus Therapeutics (FOLD) | 1.6 | $25M | 2.3M | 10.74 | |
Kinnate Biopharma | 1.5 | $23M | 1.8M | 12.61 | |
Iovance Biotherapeutics (IOVA) | 1.4 | $21M | 1.9M | 11.04 | |
Day One Biopharmaceuticals I (DAWN) | 1.3 | $21M | 1.2M | 17.90 | |
Gossamer Bio (GOSS) | 1.3 | $21M | 2.5M | 8.37 | |
Rocket Pharmaceuticals (RCKT) | 1.3 | $20M | 1.5M | 13.76 | |
Xenon Pharmaceuticals (XENE) | 1.2 | $18M | 600k | 30.42 | |
ACADIA Pharmaceuticals (ACAD) | 1.1 | $18M | 1.3M | 14.09 | |
Point Biopharma Global | 1.1 | $17M | 2.5M | 6.81 | |
Nuvalent Inc-a (NUVL) | 1.0 | $16M | 1.2M | 13.56 | |
Avidity Biosciences Ord (RNA) | 1.0 | $16M | 1.1M | 14.53 | |
Nurix Therapeutics (NRIX) | 1.0 | $16M | 1.2M | 12.67 | |
Sarepta Therapeutics (SRPT) | 0.9 | $15M | 200k | 74.96 | |
Biomea Fusion (BMEA) | 0.9 | $14M | 1.2M | 11.98 | |
Nuvation Bio Com Cl A (NUVB) | 0.9 | $14M | 4.3M | 3.24 | |
Cullinan Oncology (CGEM) | 0.9 | $14M | 1.1M | 12.82 | |
Milestone Pharmaceuticals (MIST) | 0.9 | $14M | 2.2M | 6.15 | |
Fate Therapeutics (FATE) | 0.8 | $12M | 500k | 24.78 | |
GH Research Ordinary Shares (GHRS) | 0.6 | $10M | 1.0M | 9.98 | |
Prothena Corp SHS (PRTA) | 0.5 | $8.1M | 300k | 27.15 | |
Akero Therapeutics (AKRO) | 0.5 | $7.9M | 832k | 9.45 | |
Rain Therapeutics | 0.4 | $6.5M | 1.2M | 5.56 | |
Ascendis Pharma A/S Sponsored Adr (ASND) | 0.4 | $6.5M | 70k | 92.96 | |
Ngm Biopharmaceuticals | 0.4 | $6.4M | 500k | 12.82 | |
Centessa Pharmaceuticals Sponsored Ads (CNTA) | 0.4 | $6.1M | 1.3M | 4.87 | |
2Seventy Bio Common Stock (TSVT) | 0.4 | $6.1M | 460k | 13.20 | |
DBV Technologies S A Sponsored Adr | 0.3 | $5.4M | 2.1M | 2.55 | |
Black Diamond Therapeutics (BDTX) | 0.3 | $5.0M | 2.0M | 2.46 | |
BCLS Acquisition Corp Com Cl A | 0.3 | $5.0M | 500k | 9.90 | |
Theseus Pharmaceuticals | 0.3 | $4.9M | 892k | 5.53 | |
Panacea Acquisition Corp II Cl A Shs | 0.3 | $4.9M | 500k | 9.76 | |
Oric Pharmaceuticals (ORIC) | 0.3 | $4.7M | 1.1M | 4.48 | |
Eqrx | 0.3 | $4.7M | 1.0M | 4.69 | |
89bio (ETNB) | 0.3 | $4.5M | 1.4M | 3.22 | |
Selecta Biosciences | 0.3 | $4.3M | 3.3M | 1.31 | |
Health Sciences Acq Corp 2 Ord Shs | 0.3 | $4.0M | 400k | 9.96 | |
Atreca Cl A Com (BCEL) | 0.2 | $3.9M | 2.2M | 1.79 | |
Cogent Biosciences (COGT) | 0.2 | $3.8M | 425k | 9.02 | |
Solid Biosciences | 0.2 | $3.3M | 5.3M | 0.62 | |
Mereo Biopharma Group Ads (MREO) | 0.2 | $2.5M | 2.3M | 1.12 | |
Codiak Biosciences | 0.2 | $2.4M | 850k | 2.88 | |
Essa Pharma Com New (EPIX) | 0.1 | $2.3M | 725k | 3.15 | |
Gemini Therapeutics | 0.1 | $2.2M | 1.3M | 1.69 | |
Omega Alpha SPAC Cl A | 0.1 | $2.0M | 200k | 9.85 | |
Bioatla (BCAB) | 0.1 | $2.0M | 686k | 2.85 | |
Aligos Therapeutics (ALGS) | 0.1 | $1.8M | 1.5M | 1.21 | |
MEI Pharma Com New | 0.1 | $1.8M | 2.9M | 0.60 | |
Elevation Oncology (ELEV) | 0.1 | $1.2M | 873k | 1.40 | |
Protara Therapeutics Com Stk (TARA) | 0.0 | $613k | 209k | 2.93 | |
Cabaletta Bio (CABA) | 0.0 | $572k | 540k | 1.06 | |
Nuvation Bio *w Exp 07/07/202 (NUVB.WS) | 0.0 | $75k | 267k | 0.28 | |
Bellicum Pharmaceuticals Com New | 0.0 | $68k | 57k | 1.19 | |
Surrozen W Exp 08/01/203 (SRZNW) | 0.0 | $13k | 67k | 0.20 |